Finally, KEGG pathway analysis showed that the potential targets of active compounds in RGGs were mainly enriched in pathways in cancer, the PI3K-AKT signaling pathway, the MAPK signaling pathway, and others (Figure 3G). This evidence concerns the gene AKT1 and cancer.